Ranking · Unmet Need
Research Gap Index
Burden percentile minus research-activity percentile (publications, last 5 years) within the same scope. Positive values flag cancers with high mortality burden but comparatively little literature. Caveat (Phase 1): literature counts are query-based per entity (query stored on each row); they are not aggregated over descendants.
Computedci-research-gap-v1unit: percentile pointshigher = worseAll metrics
| Rank | Δ | Cancer | Research Gap Index (percentile points) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | = | Malignant Central Nervous System Neoplasm | +66.7 | 100 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592800 |
| 2 | = | Malignant Uterine Corpus Neoplasm | +36.7 | 96.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592801 |
| 3 | = | Malignant Colon Neoplasm | +23.4 | 93.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592802 |
| 4 | = | Non-Hodgkin Lymphoma | +20 | 90 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592803 |
| 5 | = | Malignant Esophageal Neoplasm | +13.4 | 86.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592804 |
| 5 | = | Malignant Kidney Neoplasm | +13.4 | 86.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592805 |
| 7 | = | Malignant Pancreatic Neoplasm | +10 | 80 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592806 |
| 7 | = | Malignant Salivary Gland Neoplasm | +10 | 80 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592807 |
| 9 | = | Malignant Laryngeal Neoplasm | +6.7 | 73.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592808 |
| 10 | = | Malignant Vulvar Neoplasm | +6.6 | 70 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592809 |
| 11 | = | Malignant Liver Neoplasm | +6.6 | 66.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592810 |
| 12 | = | Malignant Vaginal Neoplasm | +3.3 | 63.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592811 |
| 13 | = | Malignant Lung Neoplasm | +3.3 | 60 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592812 |
| 13 | = | Multiple Myeloma | +3.3 | 60 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592813 |
| 15 | = | Cutaneous Melanoma | 0 | 53.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592814 |
| 16 | = | Malignant Ovarian Neoplasm | -3.3 | 50 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592815 |
| 16 | = | Malignant Prostate Neoplasm | -3.3 | 50 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592816 |
| 18 | = | Malignant Nasopharyngeal Neoplasm | -3.3 | 43.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592817 |
| 19 | = | Malignant Mesothelioma | -3.4 | 40 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592818 |
| 20 | = | Malignant Hypopharyngeal Neoplasm | -6.6 | 36.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592819 |
| 21 | = | Leukemia | -6.7 | 33.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592820 |
| 21 | = | Malignant Breast Neoplasm | -6.7 | 33.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592821 |
| 21 | = | Malignant Rectal Neoplasm | -6.7 | 33.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592822 |
| 24 | = | Malignant Bladder Neoplasm | -10 | 23.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592823 |
| 25 | = | Hodgkin Lymphoma | -13.3 | 20 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592824 |
| 26 | = | Malignant Anal Neoplasm | -13.4 | 16.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592825 |
| 27 | = | Malignant Penile Neoplasm | -23.3 | 13.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592826 |
| 28 | = | Malignant Testicular Neoplasm | -26.7 | 10 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592827 |
| 29 | = | Malignant Gastric Neoplasm | -26.7 | 6.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592828 |
| 30 | = | Malignant Thyroid Gland Neoplasm | -30 | 3.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592829 |
| 31 | = | Malignant Cervical Neoplasm | -40 | 0 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2592830 |
Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash 8c42e723cb5f56b0766164a9